Mosaiques Diagnostics was invited by the European Medicines Agency (EMA) to participate in a panel discussion that was held during the “Accelerating Clinical Trials in the EU” Multi-stakeholder hybrid workshop kick-off meeting on 22-23 June 2023. During the panel discussion, Mosaiques presented and discussed its proprietary model for accelerating drug development based on personalized medicine and AI approaches.

Further information can be found in the following link: https://www.ema.europa.eu/en/events/act-eu-multi-stakeholder-platform-kick-workshop